(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks fell on Tuesday, with major indexes pulling back from record levels as the recent trend of modest moves and low volume continued in the next-to-last trading day of the year. The Dow Jones industrial average was down 0.27 percent at 17,989.07, the S&P 500 was down 0.36 percent at 2,083.1 and the Nasdaq Composite was down 0.50 percent at 4,783.095.
** CIVEO CORP, $4.03, -51.27 pct
The company, which provides temporary housing for oilfield workers and miners, slashed its workforce on Monday and said revenue could fall by a third as slumping crude prices force oil producers to cut costs.
** JINPAN INTERNATIONAL LTD, $6.37, -13.33 pct
The company’s Chief Executive Zhiyuan Li and investor FNOF E&M Investment Ltd withdrew their proposal to take Jinpan private.
** IAMGOLD CORP, $2.63, +10.04 pct
** AURICO GOLD INC, $3.29, +7.17 pct
** NEWMONT MINING CORP, $19.44, +4.57 pct
** KINROSS GOLD CORP, $2.87, +6.69 pct
** ENDEAVOUR SILVER CORP, $2.26, +10.78 pct
** FIRST MAJESTIC SILVER CORP, $5.06, +7.89 pct
U.S.-listed shares of gold and silver miners rose after gold prices gained as the dollar weakened and the stock markets slid. Concerns over tension between Russia and the West also helped push the metal through key chart levels, triggering fresh buying.
** NEURODERM LTD, $12.46, +101.62 pct
The pharma company said data from a mid-stage study suggested that a higher dose of its Parkinson’s drug could provide an alternative to treatments that require surgery.
** PARAGON OFFSHORE PLC, $2.86, +6.72 pct
The offshore drilling contractor said it bought back $25.2 million senior unsecured notes for $15.3 million, including interest, this month.
** ARROWHEAD RESEARCH CORP, $8.2744, +25.09 pct
The drug developer's shares rose on a rumor that Gilead Sciences Inc may be eyeing the company for its RNA interference-based drugs, according to a report on Seeking Alpha. (bit.ly/1AgeWg7)
** AMERICAN REALTY CAPITAL PROPERTIES INC, $9.005, +6.19 pct
Activist investor Keith Meister's Corvex Management LP reported a 7.1 percent stake in the real estate investment trust. (1.usa.gov/1wwRWmL)
** BG MEDICINES INC, $0.5224, +63.25 pct
The U.S. Food and Drug Administration approved the automated version of the company’s BGM Galectin-3 test, which is used to measure galectin-3 protein levels in blood plasma.
** NEONODE INC, $2.98, +17.79 pct
The touch screen technology provider is expected to launch a touch technology for PC products at the Consumer Electronics Show in January, which could be a major trigger for its stock, Cowen & Co analysts wrote in a note.
** EXCO RESOURCES INC, $2.16, -6.49 pct
** CALLON PETROLEUM CO, $5.33, -5.33 pct
** ZAZA ENERGY CORP, $2.7645, -10.24 pct
** EP ENERGY CORP, $10, -4.58 pct
** EMERGE ENERGY SERVICES LP, $54.91, -7.93 pct
** SOUTHWESTERN ENERGY CO, $27.43, -6.13 pct
** SEVENTY SEVEN ENERGY INC, $5.8, -5.07 pct
Shares of oil and gas companies fell after Brent crude plunged to a five-and-a-half-year low of less than $57 per barrel as a global supply glut outweighed concerns of lost supply from Libya where battling militias have closed ports. Brent fell $1.14 per barrel to $56.74, its lowest since May 2009, before recovering to trade around $57.70, down 18 cents, by 1440 GMT. U.S. crude was up 10 cents at $53.71 after hitting $52.70, also its lowest since May 2009.
** CLIFFS NATURAL RESOURCES INC, $6.961, +5.15 pct
** ALPHA NATURAL RESOURCES INC, $1.74, +2.96 pct
** RIO TINTO PLC, $46.82, +2.25 pct
** VALE SA, $8.335, +1.65 pct
U.S-listed shares of iron ore miners rose after China’s iron ore and rebar futures gained as investors looked beyond the winter slump and bet that Beijing’s recent support policies would enliven steel demand in 2015.
Spot iron ore price .IO62-CNI=SI was up 4.9 percent at $71.20 per tonne
** TEKMIRA PHARMACEUTICALS CORP, $14.16, +2.16 pct
Shares of the Canadian drugmaker rose a day after a female healthcare worker in Glasgow was diagnosed with Ebola. Tekmira said last week that it would supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa next year.
The World Health Organization said on Monday that the number of people infected by Ebola in Liberia, Sierra Leone and Guinea, which are the worst affected by the outbreak, has passed 20,000, with more than 7,842 deaths in the epidemic so far. (Compiled by Manya Venkatesh in Bengaluru; Editing by Kirti Pandey)